High Tide (HITI) Q1 2026: International Revenue Jumps 60% as German Expansion Accelerates
High Tide delivered its fastest revenue growth in ten quarters, propelled by a 60% sequential surge in its German medical cannabis business and continued margin gains in Canadian retail. Strategic execution in international sourcing, disciplined cost control, and a rapidly scaling loyalty program are driving both profit expansion and free cash flow. With international operations now a material growth vector and Canadian retail outperforming a slowing market, High Tide is positioned to extend its lead in core and emerging segments.
Summary
- German Market Momentum: International segment now a core growth driver, as German revenue and shipments accelerate even before Canadian biomass arrives.
- Margin Expansion in Retail: Canadian bricks and mortar gross margin hit a three-year high, aided by white label and elite membership mix shift.
- Free Cash Flow Turnaround: Company reversed last year’s cash burn, with all segments contributing to improving profitability outlook.
Performance Analysis
High Tide’s Q1 2026 results reflect multifaceted growth across both legacy and new business lines. Total revenue reached an all-time high, driven by a sustained 25% year-over-year increase. The core Canadian bricks and mortar segment, anchored by the Canna Cabana, retail chain, contributed $150 million, representing 84% of total revenue and maintaining a $600 million annual run rate. This segment’s gross margin reached 28%, marking the fifth consecutive quarterly improvement and its highest level in over three years. The adjusted EBITDA margin for Canadian retail held steady at 9%.
International operations, led by Ramexian, medical cannabis distributor in Germany, delivered a step-change in scale. Ramexian’s Q1 revenue jumped to $25 million from just under $10 million in Q4, averaging $8 million per month, with February alone reaching a record $12 million. Gross margin in Germany improved to 20% in February, with further upside expected as Canadian-sourced biomass begins to arrive. Meanwhile, the e-commerce segment, which includes U.S. CBD and accessories, posted its first sequential revenue gain in two years, and its EBITDA drag narrowed to a four-quarter low.
- Retail Outperformance Versus Market: Canna Cabana same-store sales rose 2% in a market where total industry sales declined, and market share climbed to 12% in core provinces.
- Loyalty Program Scale: Membership surged 47% year-over-year to 2.58 million, with elite members doubling to 162,000 and driving higher-margin sales.
- Free Cash Flow Inflection: Q1 free cash flow was $2.9 million, up from negative $1.9 million a year ago, with trailing 12-month free cash flow at a five-quarter high.
High Tide’s cost discipline was evident, with general and administrative expenses at a six-quarter low of 4.1% of revenue. The balance sheet remains healthy, with $46.4 million in cash and no near-term debt maturities.
Executive Commentary
"Our domestic core bricks and mortar segment continues to outperform at peers with rising margins, which have now increased sequentially for five straight quarters and hitting 28%. At the same time, our newer international business is now picking up steam and reaching new highs since we acquired a majority interest in it."
Raj Grover, President and Chief Executive Officer
"Consolidated gross margins were 25% in Q1, consistent with Q4 last year, and just below 26% sequentially. While our medical cannabis distribution generated a lower gross margin this quarter than its usual historical performance given supply chain delays in Portugal, as Raj mentioned, we anticipate improving gross margins in this segment looking ahead as fresh biomass from Canada purchased at best-in-class terms starts arriving in Germany."
Mike Mahajan, Chief Financial Officer
Strategic Positioning
1. International Expansion as a New Growth Engine
Ramexian, German medical distributor, has rapidly become a core contributor, with management targeting further margin and volume expansion as Canadian biomass begins to flow. The company is capitalizing on early-mover advantages and actively exploring entry into the UK, where market growth rates are projected at 60% to 100% year-over-year.
2. Canadian Retail Resilience and Share Gains
Despite a slowing Canadian cannabis market, High Tide’s Canna Cabana chain continues to gain share, outperforming industry trends with positive same-store sales and higher revenue per square foot than peers. Store expansion remains focused on Ontario but also targets Alberta and Saskatchewan, with a disciplined approach to site selection to avoid redundancy and oversaturation.
3. Loyalty and White Label Mix Shift
The Canna Cabana Club, loyalty program, is driving recurring traffic and margin accretion. Elite membership, which carries a higher-margin profile, is growing at triple digits. White label product sales, currently 1.6% of revenue, are targeted to reach 20% over five years, with each new SKU providing incremental gross margin lift.
4. E-Commerce Stabilization and U.S. Policy Tailwinds
After several quarters of declines, e-commerce (CBD and accessories) saw sequential growth, aided by tech stack improvements and operational relaunches. Participation in the National Compassionate Care Council positions High Tide for potential upside if U.S. CBD regulations become more favorable, especially via Medicare pilot projects.
5. Cost Discipline and Operating Leverage
General and administrative expenses hit a six-quarter low, demonstrating operating leverage as revenue scales. Management’s focus on cost control and margin expansion is evident across all segments, supporting sustained free cash flow generation.
Key Considerations
High Tide’s Q1 2026 results demonstrate a strategic pivot toward multi-market leadership, with both Canadian retail and international medical cannabis contributing to diversified growth and profitability. The company’s execution in loyalty, margin management, and international sourcing is setting new benchmarks in operational efficiency.
Key Considerations:
- German Market Inflection: Ramexian’s rapid revenue and margin gains are poised to accelerate as Canadian biomass imports clear regulatory hurdles.
- Canadian Store Expansion Strategy: Organic growth remains focused on Ontario, but management is signaling greater selectivity due to market saturation and competition, with M&A as an additional lever.
- Loyalty and White Label Upside: Elite membership and differentiated white label products are structurally improving margin and customer retention, with long-term targets far above current contribution levels.
- E-Commerce Optionality: Early stabilization and regulatory tailwinds in the U.S. CBD business could unlock latent value, with management open to strategic transactions if they surface greater shareholder value.
Risks
Regulatory risk remains elevated in international markets, particularly in Germany where new laws governing medical cannabis access could impact growth or margin trajectory, though management expects changes to be more benign than previously feared. Canadian retail faces ongoing pressures from illicit market activity and competitive pricing, which could limit further margin expansion. Any delays in international biomass logistics or adverse macroeconomic shifts could weigh on results.
Forward Outlook
For Q2 2026, High Tide expects:
- Continued sequential growth in international revenue as Canadian biomass begins to reach Germany.
- Canadian store count to expand by 20 to 30 locations in 2026, with a focus on Ontario and select opportunities in Alberta and Saskatchewan.
For full-year 2026, management reiterated its store expansion and margin improvement targets:
- 350+ stores in Canada by year-end, with new locations driving incremental loyalty membership.
Management highlighted several factors that will shape upcoming quarters:
- Arrival of Canadian-sourced biomass in Germany expected to drive sustained profitability improvement.
- Potential entry into the UK market within 12 months, with ongoing diligence on partners and deal structure.
Takeaways
High Tide’s Q1 results mark a clear shift toward multi-market growth, with international operations now a material profit center and Canadian retail demonstrating resilience despite industry headwinds.
- International Acceleration: German business is scaling faster than modeled, with near-term catalysts from improved sourcing and regulatory clarity.
- Retail Margin and Share Leadership: Canna Cabana’s model is delivering both margin expansion and market share gains, even as industry growth slows.
- Multi-Segment Optionality: E-commerce and U.S. policy developments offer upside not currently priced into the business, while disciplined capital allocation and cost control underpin free cash flow durability.
Conclusion
High Tide’s execution in both domestic and international markets is driving record revenue, margin expansion, and free cash flow. With a proven retail model, emerging international scale, and optionality in e-commerce and white label, the company is positioned for sustained multi-segment growth and margin leadership.
Industry Read-Through
High Tide’s results underscore a structural shift in global cannabis retail, with international medical markets like Germany offering outsized growth and margin opportunities for early movers. Canadian retail is consolidating, with scale players gaining share as smaller operators exit. White label and loyalty-driven models are proving effective in margin defense. For sector peers, the ability to execute across borders, manage logistics, and leverage data-driven loyalty will increasingly separate winners from laggards. U.S. policy shifts around CBD could catalyze renewed growth in e-commerce for those positioned with compliant infrastructure and advocacy reach.